UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended March 31, 2004
OR
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number: 000-27945
ASCENDANT SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 75-2900905 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
| 16250 Dallas Parkway, Suite 102, Dallas, Texas | 75248 | |
| (Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: 972-250-0945
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES ¨ NO x
At May 14, 2004, there were approximately 21,665,900 shares of Ascendant Solutions, Inc. common stock outstanding.
FORM 10-Q
For the Quarterly Period Ended March 31, 2004
PART I.
CONDENSED CONSOLIDATED FINANCIAL INFORMATION
| ITEM 1. | CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | 1 | ||
| ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 11 | ||
| ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 16 | ||
| ITEM 4. | CONTROLS AND PROCEDURES | 16 | ||
| PART II. | ||||
| OTHER INFORMATION | ||||
| ITEM 1. | LEGAL PROCEEDINGS | 17 | ||
| ITEM 2. | CHANGES IN SECURITIES AND USE OF PROCEEDS | 17 | ||
| ITEM 3. | DEFAULTS UPON SENIOR SECURITIES | 18 | ||
| ITEM 4. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS | 18 | ||
| ITEM 5. | OTHER INFORMATION | 18 | ||
| ITEM 6. | EXHIBITS AND REPORTS ON FORM 8-K | 19 | ||
| SIGNATURE | 20 | |||
| CERTIFICATIONS | ||||
CONDENSED CONSOLIDATED BALANCE SHEETS
(000s omitted, except per share amounts)
| March 31, 2004 |
December 31, 2003 |
|||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 2,281 | $ | 2,006 | ||||
| Trade accounts receivable |
5,094 | | ||||||
| Other receivables |
134 | 46 | ||||||
| Receivable from affiliates |
43 | 52 | ||||||
| Inventories |
2,281 | | ||||||
| Prepaid expenses |
226 | 125 | ||||||
| Total current assets |
10,059 | 2,229 | ||||||
| Property and equipment, net |
573 | 17 | ||||||
| Deferred acquisition costs |
152 | 310 | ||||||
| Intangible assets |
370 | | ||||||
| Investments in limited partnerships |
274 | 285 | ||||||
| Other assets |
17 | | ||||||
| Total assets |
$ | 11,445 | $ | 2,841 | ||||
| LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 1,670 | $ | 60 | ||||
| Accounts payable to affiliates |
3 | 1 | ||||||
| Accrued liabilities |
729 | 48 | ||||||
| Notes payable, current |
431 | | ||||||
| Total current liabilities |
2,833 | 109 | ||||||
| Notes payable, long-term |
5,921 | | ||||||
| Limited partnership interests |
248 | 209 | ||||||
| Commitments and contingencies |
||||||||
| Stockholders equity: |
||||||||
| Preferred stock, $0.0001 par value: |
||||||||
| Authorized shares7,500,000 |
||||||||
| Issued and outstandingnone |
| | ||||||
| Common stock, $0.0001 par value: |
||||||||
| Authorized shares50,000,000 |
||||||||
| Issued and outstanding shares21,665,900 at March 31, 2004 and December 31, 2003 |
2 | 2 | ||||||
| Additional paid-in capital |
59,840 | 59,822 | ||||||
| Deferred compensation |
(38 | ) | (46 | ) | ||||
| Accumulated deficit |
(57,361 | ) | (57,255 | ) | ||||
| Total stockholders equity |
2,443 | 2,523 | ||||||
| Total liabilities and stockholders equity |
$ | 11,445 | $ | 2,841 | ||||
See accompanying notes to the Condensed Consolidated Financial Statements.
1
ASCENDANT SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(000s omitted, except per share amounts)
(Unaudited)
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Revenue: |
||||||||
| Real estate advisory revenues |
$ | 470 | $ | 40 | ||||
| Healthcare service revenues |
775 | | ||||||
| 1,245 | 40 | |||||||
| Cost of healthcare service revenues |
507 | | ||||||
| Gross profit |
738 | 40 | ||||||
| Operating expenses: |
||||||||
| Selling, general and administrative expenses |
847 | 347 | ||||||
| Depreciation and amortization |
6 | 14 | ||||||
| Non-cash stock option compensation |
18 | 0 | ||||||
| Total operating expenses |
871 | 361 | ||||||
| Operating loss |
(133 | ) | (321 | ) | ||||
| Investment income |
70 | 14 | ||||||
| Interest income (expense), net |
(3 | ) | 10 | |||||
| Limited partner interest in net (income) losses of partnerships |
(40 | ) | 80 | |||||
| Net loss |
$ | (106 | ) | $ | (217 | ) | ||
| Basic and diluted net loss per share |
$ | (0.00 | ) | $ | (0.01 | ) | ||
| Weighted average shares used in computing basic and diluted net loss per share |
21,665,900 | 21,230,900 | ||||||
See accompanying notes to the Condensed Consolidated Financial Statements.
2
ASCENDANT SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(000s omitted)
(Unaudited)
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Operating Activities |
||||||||
| Net loss |
$ | (106 | ) | $ | (217 | ) | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||
| Depreciation and amortization |
6 | 14 | ||||||
| Deferred compensation amortization |
9 | 9 | ||||||
| Non-cash stock option compensation |
18 | 0 | ||||||
| Limited partner interest in net income (losses) of partnerships |
40 | (80 | ) | |||||
| Changes in operating assets and liabilities, net of effects from the purchase of the Park Assets: |
||||||||
| Accounts receivable |
55 | 23 | ||||||
| Prepaid expense |
34 | 41 | ||||||
| Accounts payable |
477 | 58 | ||||||
| Accrued liabilities |
| (6 | ) | |||||
| Net cash provided by (used in) operating activities |
$ | 533 | $ | (158 | ) | |||
| Investing Activities |
||||||||
| Deferred acquisition costs |
(314 | ) | | |||||
| Payment of liabilities in connection with the acquisition of the Park Assets |
(1,350 | ) | | |||||
| Net cash acquired in connection with the acquisition of the Park Assets |
1,396 | | ||||||
| Return of capital distributions |
11 | 10 | ||||||
| Purchases of property and equipment |
(1 | ) | (11 | ) | ||||
| Net cash used in investing activities |
(258 | ) | (1 | ) | ||||
| Financing Activities |
||||||||
| Proceeds from sale of limited partnership interests |
| 128 | ||||||
| Net cash provided by financing activities |
| 128 | ||||||
| Net increase (decrease) in cash and cash equivalents |
275 | (31 | ) | |||||
| Cash and cash equivalents at beginning of period |
2,006 | 2,950 | ||||||
| Cash and cash equivalents at end of period |
$ | 2,281 | $ | 2,919 | ||||
See accompanying notes to the Condensed Consolidated Financial Statements.
3
ASCENDANT SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
| 1. | Basis of Presentation |
The unaudited condensed consolidated financial statements included herein reflect all adjustments, consisting only of normal recurring adjustments, which in the opinion of management are necessary to fairly state Ascendant Solutions, Inc.s (Ascendant Solutions or the Company) consolidated financial position, consolidated results of operations and consolidated cash flows for the periods presented. These condensed consolidated financial statements should be read in conjunction with the Companys audited consolidated financial statements included in the Companys Form 10-K for the year ended December 31, 2003 as filed with the Securities and Exchange Commission. The consolidated results of operations for the period ended March 31, 2004 are not necessarily indicative of the results to be expected for any subsequent quarter or for the entire fiscal year ending December 31, 2004. The December 31, 2003 consolidated balance sheet was derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
| 2. | Description of Business |
Ascendant Solutions is a diversified financial services company seeking to invest in, or acquire, manufacturing, distribution or service companies. The Company also conducts various real estate activities, performing real estate advisory services for corporate clients, and, through an affiliate, purchases real estate assets as a principal.
2002 TO 2003 INVESTMENTS
Ampco Partners, Ltd.
During the second quarter of 2002, the Company invested $400,000 for a 10% limited partnership interest in Ampco Partners, Ltd. (Ampco), a newly formed entity, which acquired the assets and intellectual property of the Ampco Safety Tools division of Ampco Metals Incorporated of Milwaukee, Wisconsin in a Chapter 11 bankruptcy proceeding. Ampco Safety Tools, founded in 1922, is a leading manufacturer of non-sparking, non-magnetic and corrosion resistant safety tools. These tools are designed to meet Occupational Safety and Health Administration and National Fire Protection Association requirements for use in locations where flammable vapors of combustible residues are present. Safety tools are used in industrial applications, primarily in manufacturing and maintenance operations. The Company receives quarterly distributions based upon 10% of Ampcos reported quarterly earnings before interest, taxes, depreciation and amortization expense, or EBITDA. The Companys investment in Ampco is accounted for under the equity method. The Company recognizes its proportionate share of Ampcos net income, as investment income in the consolidated statements of operations. Distributions received that exceed the Companys 10% interest in Ampcos net income are accounted for as return of capital and reduction in the investment in Ampco. The Company received distributions of approximately $35,000 and $24,000 for the quarters ended March 31, 2004 and 2003, respectively, and recorded approximately $24,000 and $14,000 in investment income for the quarters ended March 31, 2004 and 2003, respectively.
VTE, L.P.
On August 1, 2002, the Company formed a wholly owned subsidiary, which serves as the corporate general partner of VTE, L.P. (VTE), a partnership which acquired the assets (primarily software) of Venue Ticket Exchange, Inc. which was in the early stages of attempting to roll out an online, electronic ticket exchange for the purchase and sale of secondary tickets to sporting events and other entertainment venues. In connection with its formation, VTE received approximately $256,000 from the issuance of various limited partnership interests and $75,000 from the Company for general partner and limited partnership interests. Mr. Leslie, the Chairman, and Mr. Bowe, the President and CEO of Ascendant, individually, made limited partnership investments in VTE on the same terms as outside limited partnership investors. In the first and second quarters of 2003, VTE received approximately $313,500 from the issuance of additional limited partnership interests, including approximately $75,000 from the
4
Company. The Companys aggregate investment of $150,000 represents an ownership interest of 23.3% in VTE. VTE is accounted for as a consolidated entity in the consolidated financial statements.
VTE acquired the assets of Venue Ticket Exchange, Inc. for approximately $75,000 and made additional expenditures of approximately $171,000 in 2002 and 2003 for software enhancements and improvements (approximately $102,000 was capitalized and approximately $69,000 was expensed). In addition, VTE has incurred approximately $472,000 of startup, development and marketing expenses (including approximately $12,000 in the first quarter of 2004) and has approximately $1,000 in working capital remaining as of March 31, 2004.
VTE has generated no revenues and at year-end 2003, management evaluated, and wrote down, the carrying value of VTEs investment in its computer software and hardware acquired. During the first quarter of 2004, all operating activities of VTE were suspended and management of the Company continues to evaluate possible business opportunities for VTEs proprietary software including the possible sale or licensing of its software to potential third party buyers.
CRESA Capital Markets Group, L.P.
In late October 2002, the Company formed a capital markets subsidiary, CRESA Capital Markets Group, L.P., (Capital Markets) and entered into a licensing and co-marketing agreement with CRESA Partners LLC, a national real estate services firm. The Company owns 80% of Capital Markets through its general and limited partnership interests and has committed to fund up to $100,000 in Capital Markets. The remaining 20% of Capital Markets is owned, directly or indirectly, by three of its principals. In connection with its formation, Capital Markets received approximately $200,000 from the issuance of limited partnership interests to CRESA Partners LLC. During the third quarter of 2003, Capital Markets received additional funding of $80,000 ($64,000 from the Company and $16,000 from the other limited partners) in the form of partner loans. These loans were repaid with interest during the fourth quarter of 2003, from the proceeds of approximately $425,000 in real estate advisory services earned by Capital Markets from the purchase and sale of a commercial office building.
Capital Markets provides real estate financial advisory services to corporate clients on a fee basis. These services include, but are not limited to, analysis, consulting, acquisition and/or disposition of property, capital placement and acquisition, contract negotiation, and other matters related to real estate finance. Capital Markets had net service revenues of approximately $470,000 and $40,000 during the quarters ended March 31, 2004 and 2003, respectively. Since Capital Markets is still in the early development phase, its fee income can be significantly affected by a limited number of large transactions. Therefore the Company is unable to predict the level of Capital Markets continuing revenues. Capital Markets is accounted for as a consolidated entity in the consolidated financial statements. Mr. Leslie, the Chairman, also serves as an advisor to the Board of Directors of CRESA Partners, LLC. Capital Markets currently employs six people, including Mr. Leslie and certain of the Companys other affiliates.
Fairways Equities LLC
During the fourth quarter of 2003, the Company entered into a participation agreement (the Participation Agreement) with Fairways Equities LLC (Fairways), an entity controlled by Jim Leslie, the Companys Chairman, and other principals of Capital Markets, pursuant to which the Company will receive up to 20% of the profits realized by Fairways in connection with all real estate acquisitions made by Fairways. Additionally, the Company will have an opportunity, but not the obligation, to invest in the transactions undertaken by Fairways. The Companys profit participation with the principals of Fairways is subject to modification or termination by Fairways at the end of 2005 in the event that the aggregate level of cash flow (as defined in the Participation Agreement) generated by the acquired operating entities has not reached $2 million for the twelve months ended December 31, 2005. The Company is unable to determine what real estate Fairways may acquire or the cost, type, location, or other specifics about such real estate. During December 2003, the Company advanced approximately $145,000 as a deposit related to the December 2003 Fairways transaction described herein which was returned to the Company during December 2003. During December 2003, Fairways, through a partnership with an institutional investor,
5
acquired the stock of a company whose sole asset was a single tenant office building and entered into a long-term credit tenant lease with the former owner of the building. Based upon the terms of the current lease which expires in 2015 and the secured loans incurred by the partnership to fund the acquisition, which bear interest at LIBOR plus 1.75% to 2.25% and mature in 12 to 24 months, the Company expects to receive approximately $220,000 per year from the Companys share of the net rental payments, after debt service, from the partnership. These proceeds will vary if the lease is modified or terminated, if the terms of the loans are modified or if there is a default by the tenant. There can be no assurances that the Company will be able to generate the required cash flow to continue in the Fairways Participation Agreement after 2005, or that Fairways will be able to acquire additional real estate assets, that the Company will choose to invest in such real estate acquisitions or that there will be profits realized by such real estate investments. The Company does not have an investment in Fairways, but rather a profits interest through its Participation Agreement. During the first quarter of 2004 the Company earned approximately $46,000 from its profit participations in Fairways transactions, which is included in investment income.
2004 INVESTMENTS
Doughertys Holdings, Inc.
On March 24, 2004, the Company acquired, through a newly formed, wholly owned subsidiary, Doughertys Holdings, Inc. (DHI), substantially all of the assets of Park Pharmacy Corporation (the Park Assets) pursuant to the Joint Plan and the Asset Purchase Agreement (the Agreement) entered into December 9, 2003 between Park Pharmacy and DHI. Park Pharmacy had been operating as a debtor in possession since December 2, 2002. The purchased assets include all of the cash and certain other assets of Park Pharmacy and all equity interests of the following entities (each directly or indirectly wholly-owned by Park Pharmacy): (i) Doughertys Pharmacy, Inc., (ii) Park Operating GP, LLC, (iii) Park LP Holdings, Inc., (iv) Park-Medicine Man GP LLC (v) Park Infusion Services, L.P., and (vi) Park-Medicine Man, L.P.
DHI is a provider of health care services through retail pharmacies and infusion therapy/specialty pharmacy services units. Based in Dallas, Texas, DHI operates Doughertys Pharmacy Inc. in Dallas, a specialty compounding pharmacy, and three specialty pharmacies in the area between Houston and the Gulf of Mexico coast under the name Medicine Man. Three infusion therapy/specialty pharmacy services operated under the name Park Infusion Services are located in Dallas, San Antonio and Houston, Texas.
The Company acquired the Park Assets by investing, through DHI, an aggregate of approximately $1.5 million in cash, funded out of the Companys working capital, and the assumption by DHI of approximately $6.3 million in debt of Park Pharmacy. In addition, and pursuant to the asset purchase agreement, approximately $1.35 million (including $1.1 million due AmeriSourceBergen Drug Corporation described below) of acquired liabilities were paid at closing or through the period ending March 31, 2004.
In connection with the acquisition of the Park Assets, DHI entered into a new credit facility with Bank of Texas, the prior lender to Park Pharmacy Corporation. This new facility provides for three notes, aggregating approximately $5.5 million. Each note bears interest at six percent and matures in three years. Although DHI has committed to use commercially reasonable efforts to locate a replacement lender as soon as possible, DHI is obligated to make monthly payments (consisting of both interest and principal payments, as applicable) to the bank of approximately $56,000. The new credit facility is secured by substantially all of the assets of DHI, including the stock of its operating subsidiaries.
In connection with the acquisition of the Park Assets, DHI entered into a three year supply agreement with AmerisourceBergen Drug Corporation (AmerisourceBergen) pursuant to which DHI and the newly acquired indirect subsidiaries agreed to purchase prescription and over-the-counter pharmaceuticals from AmerisourceBergen through March 2007. This supply agreement will also provide DHI with pricing and payment terms that are improved from those previously provided by AmerisourceBergen to Park Pharmacy. In exchange for these improved terms, DHI has agreed to acquire 85% of its prescription pharmaceuticals and substantially all of its generic
6
pharmaceutical products from AmerisourceBergen and agreed to minimum monthly purchases of $900,000 of all products in order to obtain new favorable pricing terms. AmerisourceBergen was a creditor of the operating non-debtor subsidiaries and, in connection with the Chapter 11 bankruptcy proceeding, AmerisourceBergen agreed to accept a cash payment of approximately $1.1 million and a promissory note in the amount of approximately $750,000 payable by DHI over a period of five years, using a 15-year amortization schedule and an interest rate of six percent with the last payment being a balloon payment of the outstanding principal and accrued but unpaid interest.
Both the new credit facility with the Bank of Texas and the note with AmerisourceBergen provides for prepayment discounts in the event that these loans are retired prior to maturity.
The accounts of DHI and its subsidiaries are included in the accompanying condensed consolidated financial statements from date of acquisition on March 24, 2004. The Company has not completed its analysis of this purchase and as such the following purchase accounting information should be considered preliminary.
Through March 31, 2004, the Company has incurred a total purchase price of approximately $6.8 million which includes acquisition costs of approximately $472,000 and debt assumed of approximately $6.3 million. The Company expects to incur additional purchase costs in the second quarter of 2004 associated with the evaluation of this purchase and the costs associated with its audit of Parks historical financial statements to be included in its 8-K filing with the Securities and Exchange Commission. The acquisition will be accounted for using the purchase method of accounting. The purchase price has been preliminarily allocated as follows:
| Net cash acquired |
$ | 1,396,000 | |
| Fair value of net tangible assets acquired |
5,035,000 | ||
| Intangible assets |
370,000 | ||
| $ | 6,801,000 | ||
7
| 3. | Summary of Significant Accounting Policies |
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Healthcare service revenue
Healthcare service product sales and other revenue are reported at the estimated net realizable amounts expected to be received from individuals, third-party payors, institutional healthcare providers and others. The Company recognizes revenue from the sale of pharmaceutical products and retail merchandise as transactions occur and product is delivered to the customer. Revenue from healthcare services is recognized at the time services are provided.
Healthcare service inventories
Inventories consists of healthcare service finished goods held for resale, valued at the lower of cost, using the first-in, first-out method, or market and were comprised of approximately $1.35 million in pharmaceutical products and approximately $923,000 in retail and other merchandise at March 31, 2004:
Accounting for Impairment of Long-Lived Assets
In accordance with Statement of Financial Accounting Standards No. 144 Accounting for the Impairment or Disposal of Long-Lived Assets, the Company has adopted a policy of recording an impairment loss on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets carrying amount.
Purchase Accounting
See Note 2 to the condensed consolidated financial statements.
Stock-Based Compensation
See Note 9 to the condensed consolidated financial statements.
| 4. | Cash and Cash Equivalents |